Results 141 to 150 of about 274,125 (232)

Early Effect of 0.005% Estriol Vaginal Gel on Symptoms and Signs of Vulvovaginal Atrophy. [PDF]

J Menopausal Med, 2022
Lázaro-Carrasco de la Fuente J, Cuerva González M, González Rodríguez S, Delgado Marín JL, Cuevas Castillo C, Nieto Magro C.   +5 more
europepmc   +1 more source

Efficacy, tolerability, and endometrial safety of ospemifene compared with current therapies for the treatment of vulvovaginal atrophy: a systematic literature review and network meta-analysis. [PDF]

Menopause, 2023
Simon JA, Ferenczy A, Black D, Castonguay A, Royer C, Marouf R, Beauchemin C.   +6 more
europepmc   +1 more source

Effects of Non-Ablative Solid-State Vaginal Laser (SSVL) for the Treatment of Vulvovaginal Atrophy in Breast Cancer Survivors after Adjuvant Aromatase Inhibitor Therapy: Preliminary Results. [PDF]

J Clin Med, 2023
Lubián-López DM, Butrón-Hinojo CA, Menjón-Beltrán S, González-Mesa E, Tapiador-Albertos S, Rodríguez-Jiménez B, Fiol-Ruiz G.   +6 more
europepmc   +1 more source

Clinical Efficacy of Hormonal and Nonhormonal Agents in the Treatment of Vulvovaginal Atrophy. [PDF]

J Menopausal Med, 2021
Ilhan G, Aslan MM, Cevrioglu AS, Yıldırım M, Erkorkmaz U.   +4 more
europepmc   +1 more source

The evidence behind the use of LASER for genitourinary syndrome of menopause, vulvovaginal atrophy, urinary incontinence and lichen sclerosus: A state-of-the-art review. [PDF]

Acta Obstet Gynecol Scand, 2022
Mortensen OE, Christensen SE, Løkkegaard E.   +2 more
europepmc   +1 more source

An Open, Uncontrolled Pilot Study on 12-Week Use of VagiVital for Treatment of Vulvovaginal Atrophy in Breast Cancer Patients Undergoing Adjuvant Aromatase-Inhibitor Therapy. [PDF]

Med Devices (Auckl), 2021
Jonasson AF, Åstrom M.
europepmc   +1 more source

Effects of local laser treatment on vulvovaginal atrophy among women with breast cancer: a prospective study with long-term follow-up. [PDF]

Breast Cancer Res Treat, 2021
Veron L, Wehrer D, Annerose-Zéphir G, Suciu V, Delaloge S, Pistilli B, Chaltiel D, Pautier P.   +7 more
europepmc   +1 more source

Evaluation of the effect of multipoint intra-mucosal vaginal injection of a specific cross-linked hyaluronic acid for vulvovaginal atrophy: a prospective bi-centric pilot study. [PDF]

BMC Womens Health, 2021
Berreni N, Salerno J, Chevalier T, Alonso S, Mares P.   +4 more
europepmc   +1 more source

Experience with ospemifene in a patient with vulvovaginal atrophy and dyslipidemia: a case study. [PDF]

Drugs Context, 2020
Rodríguez SPG.
europepmc   +1 more source

Experience with ospemifene in patients with vulvovaginal atrophy treated with laser therapy: case studies. [PDF]

Drugs Context, 2020
Salcedo FL, Blanco ZE.
europepmc   +1 more source